Abstract
The controlled drug release kinetics in biochemically-triggered devices is a promising research area. These devices can act in response to specific demands from the organism, increasing therapeutic efficacy and reducing adverse effects. In this project, such strategy is proposed to obtain drug delivery devices triggered by the enzimes tyrosine hydroxylase and DOPA decarboxylase which are …